Drug interactions between clindamycin and Prenatal Low Iron
|Prenatal Low Iron (multivitamin, prenatal)|
Interactions between your drugs
There were no interactions found in our database between clindamycin and Prenatal Low Iron - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
- Clindamycin is in the drug class lincomycin derivatives.
- Clindamycin is used to treat the following conditions:
- Aspiration Pneumonia
- Bacterial Endocarditis Prevention
- Bacterial Infection
- Bacterial Vaginitis
- Bone infection
- Deep Neck Infection
- Intraabdominal Infection
- Joint Infection
- Lemierre's Syndrome
- Pelvic Inflammatory Disease
- Pneumocystis Pneumonia
- Prevention of Perinatal Group B Streptococcal Disease
- Skin or Soft Tissue Infection
- Surgical Prophylaxis
- Toxoplasmosis, Prophylaxis
Prenatal Low Iron
A total of 247 drugs are known to interact with Prenatal Low Iron.
- Prenatal Low Iron is a member of the following drug classes: iron products, vitamin and mineral combinations.
- Prenatal Low Iron is used to treat Vitamin/Mineral Supplementation during Pregnancy/Lactation.
Drug and food interactions
multivitamin, prenatal food
Applies to: Prenatal Low Iron (multivitamin, prenatal)
Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
For clinical details see professional interaction data.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No information available.|
Do not stop taking any medications without consulting your healthcare provider.